Other ·Moderate evidence ·Reviewed May 2026
Highly bioavailable choline source that rapidly crosses the blood-brain barrier. Enhances acetylcholine production for memory, focus, and athletic power output.
The bottom line
Evidence rating moderate. Most-documented uses: memory and focus, athletic power output, growth hormone support. 18 sources indexed (1991–2026), with 8 interaction records on file.
Core mechanism
Rapidly absorbed and crosses the blood-brain barrier. Releases free choline for acetylcholine (ACh) synthesis via choline acetyltransferase. Also stimulates growth hormone release via cholinergic activation of GHRH neurons. Provides glycerophosphate for phosphatidylcholine membrane synthesis.10
Take in the morning for cognitive enhancement or pre-workout for performance; hygroscopic, keep sealed7,3
Ranked by evidence and value.
Real-world pricing across three quality tiers. Assumes Alpha-GPC 50% / 99%.
Assumes 300-600 mg/day. Vendor basis: BulkSupplements powder, NOW/iHerb, Life Extension, and Amazon marketplace; 99% powder and branded capsules drive premium pricing. Updated 2026-05-28.
How much you'd eat to match a supplemental dose.
Food sources supply choline in several forms; alpha-GPC is a concentrated supplemental choline donor.
What to test, the optimal window inside the conventional range, and how long a response takes.
Alpha-GPC (300 to 600 mg) raises plasma choline acutely; small RCT evidence for power output and growth hormone response to exercise.5,1
Alpha-GPC has been associated with elevated TMAO in some users, which is debated for cardiovascular relevance. Track TMAO if cardiovascular risk is a concern.
Where this appears in the symptom-to-supplement map, ranked by relevance.
Provides choline for acetylcholine-dependent focus and processing speed.1,2
More acute-feeling than many mushroom or adaptogen options.
Evidence-based stacks that include it, with the exact dose and timing each one uses.
Most bioavailable choline source; rapidly crosses blood-brain barrier to boost acetylcholine for memory and attention1,2
Alpha-GPC is a bioavailable choline source that contributes to acetylcholine synthesis; cognitive benefit data in healthy adults are limited and preliminary, so use it as one option among cholinergic precursors and rely on a single primary choline source at a time to avoid excess intake.1,2
FMO3-related trimethylamine N-oxide pathways are relevant to choline-containing nutrients, with GWAS evidence involving choline and L-carnitine metabolism (PMID 24675659).
Recommendation: If trimethylaminuria or high TMAO concern is known, use choline donors only with clinical context and diet review.
Lion's mane promotes NGF for neuroplasticity while Alpha-GPC provides choline for acetylcholine synthesis. Synergistic cognitive enhancement.
Recommendation: Effective nootropic combination for memory and focus. Lion's mane 500-1000mg + Alpha-GPC 300-600mg.
Both are potent choline sources. Taking both at full doses may provide excessive choline, potentially causing headaches, GI distress, or fishy body odor.
Recommendation: Choose one or reduce doses of both. Rarely needed to stack both choline sources simultaneously.
B5 (pantothenic acid) is required for acetyl-CoA synthesis, which combines with choline (from Alpha-GPC) to form acetylcholine.
Recommendation: Take together to support acetylcholine synthesis. B5 provides the acetyl group, Alpha-GPC provides the choline.
Both enhance physical and cognitive performance. Creatine buffers ATP in muscles and brain; Alpha-GPC supports cholinergic signaling and growth hormone release.
Recommendation: Effective performance stack for both cognitive and physical output.
Bacopa monnieri and Alpha-GPC both support cholinergic function through different routes, and are frequently stacked to enhance memory and learning support.
Recommendation: Generally well tolerated together. Watch for signs of cholinergic excess such as headache or nausea and reduce the dose if these occur.
Phosphatidylcholine and Alpha-GPC are both choline donors, so combining them raises total choline intake and the additive cholinergic and TMAO-generating load.
Recommendation: Avoid stacking high doses of both. If combining, keep total choline within reason and watch for cholinergic symptoms such as headache, nausea, sweating, or low mood. People prioritizing cardiovascular TMAO concerns should be especially cautious.
Acetyl-L-Carnitine and Alpha-GPC act on complementary halves of the same acetylcholine-synthesis pathway, so they are commonly combined in cognitive and focus stacks. Alpha-GPC supplies the choline substrate while Acetyl-L-Carnitine helps supply the acetyl/acetyl-CoA substrate, supporting greater neurotransmitter output than either provides individually. This is a favorable, additive-to-synergistic combination rather than a risk.
Recommendation: These can be taken together safely. A typical daytime nootropic pairing is 500 to 1000 mg Acetyl-L-Carnitine with 300 to 600 mg Alpha-GPC, taken in the morning or early afternoon (both can be mildly stimulating, so avoid late-evening dosing). Take with or without food per tolerance. No mandatory time separation is needed.
Both donepezil and Alpha-GPC increase cholinergic activity. Donepezil inhibits acetylcholinesterase; Alpha-GPC provides choline for acetylcholine synthesis. Combined use may cause cholinergic excess (nausea, diarrhea, bradycardia).
Recommendation: If combining, start Alpha-GPC at low doses (300mg) and monitor for cholinergic side effects (nausea, diarrhea, muscle cramps, bradycardia).
Numbered references. Citations throughout the page link here.
Systematic review of 358 participants across 3 RCTs found alpha-GPC significantly improved clinical conditions in patients with dementia disorders.
Sohn M, Park YH, Lim S. Effects of choline alfoscerate on cognitive function and quality of life in type 2 diabetes: A double-blind, randomized, placebo-controlled trial. Diabetes, obesity & metabolism. 2025
Alpha-GPC supplementation significantly increased cognitive performance in young healthy males as measured by Stroop Total Score and completion time.
Lee W, Kim M. Comparative study of choline alfoscerate as a combination therapy with donepezil: A mixed double-blind randomized controlled and open-label observation trial. Medicine. 2024
RCT of 41 older adults found 12 weeks of egg yolk choline supplementation (300 mg/day, containing PC, LPC, and alpha-GPC) significantly improved verbal memory scores compared to placebo.
Harrington RN. Effects of branched chain amino acids, l-citrulline, and alpha-glycerylphosphorylcholine supplementation on exercise performance in trained cyclists: a randomized crossover trial. Journal of the International Society of Sports Nutrition. 2023
No significant differences between groups for isometric strength or psychomotor performance after 7 days of alpha-GPC supplementation.
Alpha-GPC restored learning and memory impaired by scopolamine-induced amnesia, demonstrating its cholinergic mechanism of action.
EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA), Turck D, Bohn T et al.. Safety of L-alpha-glycerylphosphorylcholine (L-alpha-GPC) from soya phospholipids (lecithin) as a novel food pursuant to Regulation (EU) 2015/2283. EFSA journal. European Food Safety Authority. 2026
Cao J, Su E. Unlocking the potential of l-α-glycerylphosphorylcholine in the food industry: From safety approvals to market prospects. Comprehensive reviews in food science and food safety. 2025
Ponomareva EV, Androsova LV, Krinsky SA et al.. [Efficacy and safety of choline alfoscerate in the preventive therapy of dementia in elderly patients with Mild Cognitive Impairment: a three-year prospective comparative study]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 2024
Alpha-GPC supplementation increases cecal TMA and plasma TMAO production, which has been linked to accelerated atherosclerosis progression.
Gavrilova SI, Kolykhalov IV, Ponomareva EV et al.. [Clinical efficacy and safety of choline alfoscerate in the treatment of late-onset cognitive impairment]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 2018
Population-based cohort (N=12M, South Korea) found alpha-GPC users had 46% higher 10-year stroke risk (aHR 1.46, 95% CI 1.43-1.48) in dose-response manner vs nonusers.
This page is educational. Do not start, stop, or change a supplement or medication based on it without checking with a qualified healthcare professional.
Use this with your stack
Add it to your stack, see how it interacts with everything else you take, and get a Stack Score that updates the moment it does.
NutriStack is an informational and organizational tool, not a medical service, and not a substitute for professional advice. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or medication.
NutriStack